This Week in Psychedelics - 10.2.20

Cannabis

• FBI: Marijuana Arrests Decline Year-Over-Year, But Still Outpace Arrests for All Violent Crimes (NORML)

• Colorado Governor Grants Thousands Of Marijuana Pardons With New Clemency Powers (Marijuana Moment)

• New Jersey: Lawmakers Approve Telemedicine for Medical Cannabis Authorizations (NORML)

• Hawaii: Governor Legalizes Sales of Edible Products by Licensed Medical Cannabis Dispensaries (NORML)

• Democrats Remove Marijuana Research Bill From House Floor Schedule After Briefly Listing Possible Vote (Marijuana Moment)

• Michigan: Lawmakers Approve Marijuana Expungement Legislation (NORML)

• Where President Donald Trump Stands On Marijuana (Marijuana Moment)

• New Jersey: Voter Support Solidly in Favor of Marijuana Legalization Ahead of Ballot Initiative Vote (NORML)

• Study: Nearly Thirty Percent of Women Report Having Used Cannabis for Menopause Symptoms (NORML)

LSD

• LSD, Music, and the Mysteries of Consciousness (Psychedelic Science Review)

• Crystal Structure of LSD & 5-HT2AR- Part 1: Capturing the First Steps of a Psychedelic Trip (Psychedelic Science Review)

Magic Mushrooms

• Oregon Psilocybin Initiative Gets Boost From New TV Ad But Draws Opposition From Unlikely Source (Marijuana Moment)

• Psygen Labs To Supply NeonMind With Psilocybin For Weight Loss Study (Green Market Report)

• Denver Mushroom Dealer Pleads Guilty in Federal Court (Westword)

• Psilocybin Patents: Predictors and Drivers of Company Value? (Psilocybin Alpha)

MDMA

• ATAI Life Sciences Company, EmpathBio, Dives Into MDMA Derivatives, Calls MAPS’ Approach “MDMA 1.0” (Psymposia)

• LGBTQIA Providers and Participants in MDMA Clinical Trials with Terence Ching (Chacruna)

DMT

• Combatting resistant depression with DMT and digital therapy (Health Europa)

Ayahuasca

• Dating My Ayahuasca Shaman: Sex, Power, and Consent (Chacruna)

• Women’s Historical Influence on “Set and Setting” (Chacruna)

Iboga

• In Defending Hunter, Biden Showed Us His Potential (Rolling Stone)

• Why Ibogaine Is Not the Answer to the Opioid Crisis (Chacruna)

Synthetic Cannabinoids

• Crystal Structure of CB1 and MDMB-Fubinaca Gives Insight Into Synthetic Cannabinoids’ Potency (Psychedelic Science Review)

Ketamine

• Statement on Ketamine Sedation and Law Enforcement from the American College of Medical Toxicology (PR Web)

• Study reveals how subanesthetic ketamine is effective in treating adult amblyopia (News-Medical.net)

• A Dose of Ketamine Can Treat 'Lazy Eye' in Adults (Futurity)

Miscellaneous

• Psychedelic Gold Rush? Psilocybin Startup Compass Pathways Goes Public at More than $1B (DoubleBlind)

• Michigan Prosecutor Won’t Pursue Psychedelics Possession Cases Following Local Decriminalization Vote (Marijuana Moment)

• Decriminalize Nature Promotes New Oakland Initiative While Condemning Fellow Activists (Lucid News)

• Vermont Democratic Party Platform Calls For Decriminalizing Drugs And Legalizing Marijuana Sales (Marijuana Moment)

• Field Trip Psychedelics Inc. Announces Successful GLP Synthesis, Results From Initial Preclinical Testing for FT-104, its First Molecule in Development (PR Newswire)

• Psychedelics as a Catalyst for Existential Joy (Sam Woolfe)

• ‘The Word of God in a Molecule’: Turning to Psychedelics During a Pandemic (Bedford + Bowery)

• Did Early Christians Use Psychedelics? (The Daily Beast)

• Mydecine Innovations Group Announces The Official Mindleap Health Mobile App Launch in IOS and Android Stores Today (Psilocybin Alpha)

• Psychedelic-Assisted Therapy in the Post-Pandemic Era (Psychedelic Science Review)

• Psychedelic Industry 101: How to Get Involved (Reality Sandwich)

• The Systemic Culture Problems of the Psychedelics Industry (Lucid News)

• How I Used Psychedelics To Support My Sobriety (Yes, You Read That Right) (mindbodygreen)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalogue how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 9.25.20

Cannabis

• Vermont Bills To Legalize Marijuana Sales And Expunge Convictions Head To Governor’s Desk (Marijuana Moment)

• Barbados Is Inches Away From Decriminalizing Cannabis Possession (MERRY JANE)

• Delta-8-THC Promises to Get You High Without the Paranoia or Anxiety (Discover Magazine)

• New Marijuana Coalition Unveils Plan To Legalize Interstate Cannabis Commerce (Marijuana Moment)

• ‘Failure’ to embrace medical cannabis has caused “preventable deaths” – report (Cannabis Health News)

• Using weed during pregnancy linked to psychotic-like behaviors in children, study finds (CNN)

• Texas Ban On Smokable Hemp Lifted Until 2021, Judge Rules (Marijuana Moment)

• Playboy Gets Serious About Cannabis Law Reform Advocacy With New Partnership, Grants (Forbes)

• Study: Use of Cannabis Long-Term Not Associated with Cognitive Differences in Older Adults (NORML)

• FDA Explains Effects Of CBD And Marijuana Compounds Based On Sex And Gender Differences (Marijuana Moment)

• Survey: Nearly One in Three Migraine Sufferers Have Used Cannabis for Symptom Management, Most Report It to Be Effective (NORML)

• South Dakota Voters Support Medical And Recreational Marijuana Initiatives, New Opposition Poll Finds (Marijuana Moment)

Magic Mushrooms

• Oregon Democratic Party Endorses Legal Psilocybin Therapy And Drug Decriminalization Ballot Measures (Marijuana Moment)

• MindMed and Liechti Lab Announce R&D Collaboration On Psilocybin (PR Newswire)

• Inside 9/20, the Holiday for Psychedelic Mushrooms (Rolling Stone)

MDMA

• Ecstasy use down during pandemic; Psychedelics draw more interest (NL Times)

Ayahuasca

• Tribute to Dr. Domingos Bernardo, the Legal Expert who Fought for the Liberation of Ayahuasca in Brazil (1941-2020) (Chacruna)

Novel Psychoactive Substances

• Mindset Pharma Reports Positive Results of Synthetic Psilocybin-Inspired Compounds (Lucid News)

Ketamine

• This Wearable Ketamine Device Could Be The Future Of Pain Management (Forbes)

Miscellaneous

• Ann Arbor Decriminalizes Psychedelics (DoubleBlind)

• COMPASS Pathways Closes $147 million IPO (Psilocybin Alpha)

• President Behind Mexico’s War on Drugs Admitted It Was ‘Unwinnable’ (VICE)

• The Legal Response to Breonna Taylor's Death Shows How Drug Prohibition Transforms Murder Into Self-Defense (Reason)

• Who Will Benefit From Psychedelic Medicine? (The Washington Post)

• Mind Cure Becomes Latest Publicly-Traded Psychedelic Company (Psilocybin Alpha)

• 60 Percent of DC Voters Support Plant Medicine Decriminalization (Lucid News)

• MindMed Applies to List on Nasdaq (Psilocybin Alpha)

• Can Psychedelics Rekindle Ancient Animism in Modern Society? (DoubleBlind)

• Meet the ‘psychedelic concierge’ to the stars (Page Six)

• Why Psychedelic Therapy is Effective at Combating Addiction (Sam Woolfe)

• Mindleap Health Announces The Launch of The World’s First Telehealth Platform For Psychedelic Integration (Psilocybin Alpha)

• Dr. Michael Mithoefer & Ann Mithoefer from MAPS Join AWAKN's Scientific Board (Stockhouse)

• The Psychedelic Election is an Internet Addiction (Lucid News)

• An Interview with Mariavittoria Mangini (Chacruna)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalogue how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.